MarketCap
Facebook
X
TelegramQuartalsbericht 2025-Q3
hinzugefügt 12.11.2025
Atara Biotherapeutics Kurzfristige Verbindlichkeiten 2011-2026 | ATRA
Kurzfristige Verbindlichkeiten Jährlich Atara Biotherapeutics
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 135 M | 142 M | 78.9 M | 106 M | 82.9 M | 36.7 M | 40 M | 27.6 M | 9.68 M | 9.71 M | 2.72 M | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 142 M | 2.72 M | 61 M |
Kurzfristige Verbindlichkeiten anderer Aktien in der Pharmaeinzelhändler
| Name | Kurzfristige Verbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Acer Therapeutics
ACER
|
19 M | - | 2.71 % | $ 14 M |  USA |
 |
Acorda Therapeutics
ACOR
|
228 M | - | -24.86 % | $ 820 K | USA |
 |
AgeX Therapeutics
AGE
|
5.91 M | - | -10.17 % | $ 12.2 K | USA |
 |
Aeglea BioTherapeutics
AGLE
|
58.7 M | - | - | $ 1.01 B | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
25.2 M | - | - | $ 26.5 M | USA |
 |
AbCellera Biologics
ABCL
|
64.3 M | $ 3.55 | -2.18 % | $ 1.06 B |  Canada |
 |
I-Mab
IMAB
|
576 M | - | - | $ 866 M |  China |
 |
ADMA Biologics
ADMA
|
69.5 M | $ 15.66 | -5.32 % | $ 3.73 B | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
1.62 B | - | - | $ 40.3 B | USA |
 |
Aptorum Group Limited
APM
|
4.34 M | $ 0.82 | -0.73 % | $ 4.47 M | China |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
1.77 M | - | -1.52 % | $ 24.7 M | USA |
 |
Akero Therapeutics
AKRO
|
39.8 M | - | - | $ 3.67 B | USA |
 |
Akouos
AKUS
|
16.8 M | - | 0.23 % | $ 488 M | USA |
 |
Alpine Immune Sciences
ALPN
|
58 M | - | - | $ 2.17 B | USA |
 |
AlloVir
ALVR
|
5.24 M | - | 4.14 % | $ 49.1 M | USA |
 |
Apellis Pharmaceuticals
APLS
|
324 M | $ 20.16 | 1.51 % | $ 2.54 B | USA |
 |
Ampio Pharmaceuticals
AMPE
|
2.38 M | - | -11.43 % | $ 502 K | USA |
 |
ANI Pharmaceuticals
ANIP
|
194 M | $ 75.5 | -1.35 % | $ 1.46 B | USA |
 |
Applied Therapeutics
APLT
|
71.2 M | - | - | $ 8.42 M | USA |
 |
Autolus Therapeutics plc
AUTL
|
60.7 M | $ 1.48 | -9.2 % | $ 378 M |  Britain |
 |
Aravive
ARAV
|
22.1 M | - | -13.39 % | $ 1.45 M | USA |
 |
Adverum Biotechnologies
ADVM
|
22.9 M | - | - | $ 86.2 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
556 M | - | - | - |  Russia |
 |
Athersys
ATHX
|
29.9 M | - | 3.77 % | $ 22.4 M | USA |
 |
ARCA biopharma
ABIO
|
13 M | - | 1052.0 % | $ 415 M | USA |
 |
Corcept Therapeutics Incorporated
CORT
|
166 M | $ 34.35 | -3.75 % | $ 3.57 B | USA |
 |
Corbus Pharmaceuticals Holdings
CRBP
|
31.9 M | $ 7.8 | -7.36 % | $ 33.8 M | USA |
 |
CorMedix
CRMD
|
11.4 M | $ 6.32 | -11.24 % | $ 322 M | USA |
 |
AVEO Pharmaceuticals
AVEO
|
18.7 M | - | - | $ 521 M | USA |
 |
Champions Oncology
CSBR
|
23.9 M | $ 5.79 | -3.58 % | $ 79.1 M | USA |
 |
Axsome Therapeutics
AXSM
|
379 M | $ 160.44 | -2.22 % | $ 7.98 B | USA |
 |
BridgeBio Pharma
BBIO
|
288 M | $ 65.38 | -1.74 % | $ 12.5 B | USA |
 |
Denali Therapeutics
DNLI
|
102 M | $ 19.69 | -3.34 % | $ 3.24 B | USA |
 |
Brainstorm Cell Therapeutics
BCLI
|
8.98 M | - | -2.5 % | $ 5.88 M | USA |
 |
BioDelivery Sciences International
BDSI
|
82.4 M | - | -4.8 % | $ 255 M | USA |
 |
Acasti Pharma
ACST
|
1.93 M | - | 4.01 % | $ 150 M | Canada |
 |
BeiGene, Ltd.
BGNE
|
1.83 B | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Edesa Biotech
EDSA
|
1.83 M | $ 3.8 | -10.9 % | $ 12.2 M | USA |
 |
Equillium
EQ
|
27.6 M | $ 1.79 | 2.0 % | $ 62.2 M | USA |
 |
Bellicum Pharmaceuticals
BLCM
|
3.77 M | - | -9.72 % | $ 5.89 M | USA |
 |
Berkeley Lights
BLI
|
45.5 M | - | -7.31 % | $ 87 M | USA |
 |
Bellerophon Therapeutics
BLPH
|
5.4 M | - | -74.18 % | $ 955 K | USA |
 |
BioMarin Pharmaceutical
BMRN
|
759 M | $ 60.47 | 0.07 % | $ 11.6 B | USA |
 |
Eton Pharmaceuticals
ETON
|
16.2 M | $ 17.04 | -2.77 % | $ 437 M | USA |